| Ashley Reid, | |
|
9409 N Haggerty Rd, Plymouth, MI 48170-4696 | |
| (734) 656-8232 | |
| Not Available |
| Full Name | Ashley Reid |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 6 Years |
| Location | 9409 N Haggerty Rd, Plymouth, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114309069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6801110820 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Transformational Services Llc | 8820219322 | 22 |
News Archive
Between 33 and 77 million people in Bangladesh have been exposed to arsenic in the drinking water-a catastrophe that the World Health Organization has called "the largest mass poisoning in history." A new study published in the current issue of the medical journal The Lancet provides the most complete and detailed picture to date of the high mortality rates associated with this exposure, which began with the widespread installation of tube wells throughout the country 30 years ago-a measure intended to control water-bourne diseases.
Scientists at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), a step toward developing treatments for the newly emerging and often-fatal disease.
A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).
› Verified 8 days ago
| Entity Name | Transformational Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780090258 PECOS PAC ID: 8820219322 Enrollment ID: O20141027001839 |
News Archive
Between 33 and 77 million people in Bangladesh have been exposed to arsenic in the drinking water-a catastrophe that the World Health Organization has called "the largest mass poisoning in history." A new study published in the current issue of the medical journal The Lancet provides the most complete and detailed picture to date of the high mortality rates associated with this exposure, which began with the widespread installation of tube wells throughout the country 30 years ago-a measure intended to control water-bourne diseases.
Scientists at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), a step toward developing treatments for the newly emerging and often-fatal disease.
A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Reid, 9409 N Haggerty Rd, Plymouth, MI 48170-4696 Ph: () - | Ashley Reid, 9409 N Haggerty Rd, Plymouth, MI 48170-4696 Ph: (734) 656-8232 |
News Archive
Between 33 and 77 million people in Bangladesh have been exposed to arsenic in the drinking water-a catastrophe that the World Health Organization has called "the largest mass poisoning in history." A new study published in the current issue of the medical journal The Lancet provides the most complete and detailed picture to date of the high mortality rates associated with this exposure, which began with the widespread installation of tube wells throughout the country 30 years ago-a measure intended to control water-bourne diseases.
Scientists at Dana-Farber Cancer Institute have identified natural human antibodies against the virus that causes Middle East Respiratory Syndrome (MERS), a step toward developing treatments for the newly emerging and often-fatal disease.
A small molecule designed to detect cyanide in water samples works quickly, is easy to use, and glows under ultraviolet or "black" light.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Nymox Pharmaceutical Corporation provided an update today on the Company's Phase 3 pivotal trials for NX-1207, Nymox's investigational drug for benign prostatic hyperplasia (BPH).
› Verified 8 days ago
Mrs. Ann Martin Schueller, L.M.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 159 S Harvey St, Plymouth, MI 48170 Phone: 248-842-5323 | |
Ms. Tyler James Pollack, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 34 N Main St, Suite 300, Plymouth, MI 48170 Phone: 734-546-3833 | |
Cora Marie Kutnick, LLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 496 W Ann Arbor Trl Ste 202, Plymouth, MI 48170 Phone: 734-414-1373 | |
Ms. Kathleen Price Irvin, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 340 N Main St, Plymouth, MI 48170 Phone: 734-454-3560 | |
Adriana Petrucci, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1308 S Main St, Plymouth, MI 48170 Phone: 734-451-3400 | |
Cynthia Barnwell, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 409 Plymouth Rd, Ste 190, Plymouth, MI 48170 Phone: 734-454-3560 | |
Anna Schankowski, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9409 N Haggerty Rd, Plymouth, MI 48170 Phone: 734-559-3540 Fax: 734-667-3925 |